Paul Palevsky, MD, FNKF – Chair; NKF President
Dr. Palevsky is Professor of Medicine and Clinical and Translational Science in the Renal-Electrolyte Division at the University of Pittsburgh School of Medicine and is Chief of the Renal Section at the VA Pittsburgh Healthcare System. He completed his undergraduate and medical education at Northwestern University followed by internship and residency training in internal medicine and fellowship training in nephrology at the University of Pennsylvania. Dr. Palevsky joined the faculty at the University of Pittsburgh in 1989, where he has remained since. Dr. Palevsky's research has primarily focused on acute kidney injury and critical care nephrology. He was the study chair of the VA/NIH Acute Renal Failure Trial Network (ATN) study evaluating intensity of renal replacement therapy in critically ill patients with acute kidney injury and currently serves as co-chair of the PRESERVE trial, evaluating the comparative effectiveness of saline and bicarbonate and the efficacy of N-acetylcysteine in preventing kidney damage following angiography. Among other clinical trials, Dr. Palevsky was a member of the planning and executive committee of the VA NEPHRON-D study, which compared monotherapy with an angiotensin receptor blocker to combination therapy with both an angiotensin blocker and an angiotensin converting enzyme inhibitor in slowing progression of diabetic kidney disease and is a member of the steering committees for the EUPHRATES trial, evaluating extracorporeal endotoxin adsorption in severe sepsis. Dr Palevsky has published more than 200 original articles, reviews and book chapters, serves as a deputy editor of the Clinical Journal of the American Society of Nephrology and is section editor for Renal Failure for UpToDate. He is a former member of the board of directors and past chair of the Quality, Safety and Accountability committee of the Renal Physicians Association, and is the vice-chair of the board of directors of Quality Insights Renal Network 4 (ESRD Network 4).
Morgan Grams, MD, MHS, PhD
Dr. Grams is a nephrologist and Associate Professor with a joint appointment in the Departments of Medicine and Epidemiology at Johns Hopkins University in Baltimore, Maryland, USA. Dr. Grams holds academic degrees from Yale, Columbia, and Johns Hopkins University. She completed an internal medicine residency at New York Presbyterian-Columbia University and a nephrology fellowship at The Johns Hopkins University School of Medicine. Dr. Grams is Director of Nephrology Initiatives for the Chronic Kidney Disease Prognosis Consortium, an 11-million participant, global consortium, and she also maintains active research programs in the metabolomics and genomics of kidney disease as well as drug safety in chronic kidney disease.
Elizabeth Yakes Jimenez, PhD, RDN, LD
Dr. Yakes Jimenez is the Director of the Nutrition Research Network (NRN) for the Academy of Nutrition and Dietetics and a Research Associate Professor in the Departments of Pediatrics and Internal Medicine at the University of New Mexico Health Sciences Center. She has a bachelor’s degree in human nutrition and a master’s degree in public health nutrition from Case Western Reserve University, and a PhD in epidemiology from the University of California, Davis. In her role as the Director of the NRN, she is currently overseeing research studies examining underutilization of Medicare medical nutrition therapy benefits for patients with non-dialysis dependent chronic kidney disease, and implementation of evidence-based nutrition practice guidelines for chronic kidney disease.
Marva Moxey-Mims, MD, FASN
Dr. Moxey-Mims is the Division Chief of Nephrology at the Children’s National Hospital. Prior to that, she served as deputy director for clinical science in the Division of Kidney, Urologic and Hematologic Diseases at the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health in Bethesda, Maryland. There she oversaw a portfolio of research including trials for kidney disease and genitourinary dysfunction in adults and children, and director of the pediatric nephrology program. In addition, she managed the division’s small business grants for kidney research.
Dr. Moxey-Mims’ focus at Children’s National is on clinical research to improve the care of children with kidney disease, and as a tool to educate trainees. She received an undergraduate degree from McGill University in Montreal, Canada, and a medical degree from Howard University in Washington, D.C. She completed a pediatric residency and clinical pediatric nephrology training at Children’s National, followed by a research fellowship at the National Institute of Allergy and Infectious Diseases at the NIH. She is board-certified in pediatrics and pediatric nephrology. Dr. Moxey-Mims is a member of several national committees and has more than 90 scientific publications, including peer-reviewed articles and book chapters.
Michael V. Rocco, MD, MS, FACP, FNKF
Dr. Rocco is Professor of Medicine at Wake Forest University in Winston-Salem, North Carolina. He received his MD degree from Vanderbilt University in Nashville, Tennessee and also served his Internal Medicine residency at Vanderbilt. He completed a nephrology fellowship at the University of Pennsylvania in Philadelphia, Pennsylvania and received a master's degree in epidemiology at Wake Forest University. He has been on the faculty of the Wake Forest University School of Medicine since 1991 and currently holds the Vardaman M. Buckalew Jr. Chair in Nephrology. He has more than 100 manuscripts and book chapters in the areas of hemodialysis, peritoneal dialysis, nutrition, chronic renal failure and epidemiology. He has served as the clinical center Principal Investigator at Wake Forest for several NIH trials, including the HEMO Study, the Acute Renal Failure Trial Network (ATN), the Dialysis Access Consortium (DAC) and the Frequent Hemodialysis Network (FHN). In the HEMO Study he served as the Chair of the Nutrition committee and the Vice-Chair of the Outcomes Committee. In the FHN Trial, he is the Clinical Core Consortium PI for the Nocturnal Trial and the Chair of the Outcomes Committee. Dr. Rocco is currently the Chair of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (KDOQI); he served as the Vice-Chair for KDOQI from 2003 - 2007 and was the vice-chair for the NKF KDOQI Hypertension Work Group.
Sylvia E. Rosas, MD, MSCE
Dr. Rosas is a nephrologist and epidemiologist at the Joslin Diabetes Center in Boston, Ma. She is the Director of the Latino Kidney Clinic and an Associate Professor of Medicine at Harvard Medical School. She also is a nephrologist at the Beth Israel Deaconess Medical Center. Her primary research focus is on the epidemiology of metabolic and cardiovascular disease complications in patients with chronic kidney disease particularly diabetic kidney disease. She has also evaluated health disparities in individuals with CKD particularly in those of Hispanic/Latino background.
Dr. Rosas is the clinical center PI in the NIDDK-funded multicenter APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) that evaluates the role of the APOL1 gene in kidney transplant outcomes. She is also the PI for the Kidney Precision Medicine Program (KPMP) Chronic Kidney Disease recruitment site at Joslin Diabetes Center. KPMP aims to ethically obtain and evaluate human kidney biopsies in order to create a kidney tissue atlas, define disease subgroups, and identify critical cells, pathways, and targets for novel therapies. She has received numerous awards including the National Kidney Foundation (NKF) of New England Physician of the Year in 2017 and National Hispanic Medical Association Fellow of the Year Award. In addition to being a long-time volunteer for the National Kidney Foundation, she is the president-elect and will begin her term as President in October 2022. On a local level, she has been a member of the medical board of the NKF NE chapter. She is a member of the Editorial Board of the Clinical Journal of the American Society of Nephrology and the Advances of Chronic Kidney Disease Journal. Dr. Rosas served as the Chair of the Minority Affairs Committee of the Organ Procurement and Transplant Network/United Network for Organ Sharing (UNOS). Dr. Rosas has been the secretary for Women in Nephrology as well as Program Committee Chair for the NIDDK Network for Minority Health Research Investigators.
Leah Foster Smith, MSN, APRN, FNP-BC, CNN-NP, FNKF
Leah Foster Smith received her BSN & MSN-FNP from University of North Carolina at Charlotte in 1996 & 2001, respectively. She joined Metrolina Nephrology Associates, based in Charlotte, NC, in 2001 as an ANCC Board-certified FNP. Leah was promoted to Director of Advanced Practitioners in 2007 and now supervises Supervising the largest group of nephrology APs in the US with a total of 30 Nephrology Advanced Practitioners. She is also an AP practice consultant with Clear Edge Medical Management assisting multiple nephrology practice in the utilization of nephrology APs, AP-led CKD clinics, focused dialysis rounding models and AP leadership in nephrology practice settings. Leah is also the creator and chair of formalized CKD program managing over 22,000 CKD patients with quality data showing 35% reduction in CVC start rates on patients transitioning to dialysis when APs are involved in care along with a development of a formalized new nephrology AP training program that includes both clinical and didactic courses assisting new nephrology APs integrate into nephrology practice settings including CKD, outpatient dialysis and acute nephrology care settings. Leah is now owner and Chief Education Officer in Interactive Nephrology providing educational support for nephrology practices and APs across the country. She also serves as practice lead in the legacy Charlotte ESCO with Fresenius Health Partner.
Leah currently serves in many national nephrology organizations at local, state and national levels. Leah is involved with NKF with her current role as Chair of the National Council of APs and member of the NC Medical Advisory Board. In addition to her volunteer work with NKF, she has been involved with ANNA, RPA, and the NNCC.
Wendy St. Peter, PharmD, FCCP, BCPS, FNKF
Dr. St. Peter is a Professor in the College of Pharmacy at the University of Minnesota. She received her Doctor of Pharmacy degree from the University of Texas Health Science Center, where she also completed a fellowship in adult medicine. She served as a clinical practitioner at Hennepin County Medical Center in Minneapolis for several years where she provided medication therapy management of dialysis and chronic kidney disease (CKD) patients as part of a interprofessional team. She was Associate Dean and Director, Division of Professional Education in the College of Pharmacy from 1997-2000. In 2000, she became an investigator with the Chronic Disease Research Group and also with the United States Renal Data System (USRDS, 2000-2014) in Minneapolis. Dr. St. Peter's career has been focused on improving medication management and drug safety in patients with chronic kidney disease (CKD) to improve health outcomes. She conducts clinical and pharmacoepidemiologic research using Medicare, health system as well as commercial datasets. She conducted and helped design the secondary study of the large prospective Dialysis Clinical Outcomes Revisited (DCOR) trial, linking trial data with Centers for Medicare & Medicaid Services data to determine additional clinical outcomes and economic costs. Dr. St. Peter holds fellowships in the American Society of Nephrology, American College of Clinical Pharmacy and the National Kidney Foundation. She has served on several national technical expert panels for medication-related safety and quality measurement issues. Her current research interests include new models of care for CKD patients as well as treatment of CKD anemia, mineral and bone disorder, and the intersection of management of heart failure, CKD and/or acute kidney injury.